Ellipsis was founded in 1997 by a group of
medical doctors and researchers who research complex human
diseases that have a strong genetic basis. Ellipsis has leveraged
this expertise in disease gene discovery and genomic technologies
in order to develop a single nucleotide polymorphism (SNP)
genotyping service to analyze genetic diversity for academic,
industry and government clients. The company offers custom
assay development, SNP validation and data analysis, providing
complete cost effective solutions on a fee-for-service basis.
